Targeted Strategies for Today's Evolving Markets

MissionIR Blog

DARA BioSciences, Inc. (DARA) Starts Presentation at 2015 Marcum MicroCap Conference

DARA BioSciences is an oncology supportive care pharmaceutical company dedicated to providing health care professionals a portfolio of medicines to help cancer patients stick to their therapy and manage side effects arising from their cancer treatment. DARA holds exclusive U.S. marketing rights to the Soltamox(tamoxifen citrate) oral solution, Gelclair oral rinse gel, and Oravig(miconazole). For more information, visit the company’s website at

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Comments are closed.